NIH-funded research R01 grant

Investigating how specific signaling in brain cells affects glaucoma-related cell death

Official title: Compartmentalized cAMP signaling in reactive astrocytes

Funded at Stanford University · NIH-11210519 · Data updated 2026-11-12

This study is looking at how certain brain cells called reactive astrocytes behave in glaucoma, with the hope of finding new ways to protect the cells in your eyes that are important for vision, so that we can develop better treatments for people with glaucoma.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 1, 2024
Project endApril 30, 2025
Funding year2025
Award (this year)$41,072
NIH project number3R01EY033816-01A1S1
Project IDNIH-11210519 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with glaucoma or other optic neuropathies who are experiencing vision loss.

Less likely to help

Patients with conditions unrelated to glaucoma or those who have already lost significant vision may not benefit from this research.

What this research studies

This research focuses on understanding the role of reactive astrocytes in glaucoma, a leading cause of irreversible blindness. By examining how compartmentalized cAMP signaling affects these brain cells, the study aims to uncover mechanisms that could protect retinal ganglion cells from death. Using advanced techniques like single-cell RNA sequencing, researchers will analyze the cellular responses to stress and how these responses can be manipulated to improve cell survival. The goal is to identify potential therapeutic targets that could lead to better treatments for glaucoma patients.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent vision loss in glaucoma patients by protecting critical retinal cells.

How similar studies have gone: Previous research has shown promise in targeting astrocytes for neuroprotection in various neurological conditions, suggesting that this approach may yield beneficial results.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Goldberg, Jeffrey L — Stanford University
  • Study coordinator: Goldberg, Jeffrey L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.